Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/1996
09/25/1996EP0733378A2 Preparation of autologous plasma and fibrin gel
09/25/1996EP0733213A1 Process for the production of combinatorial compound libraries
09/25/1996EP0733104A1 Purification of vitamin-k dependent proteins by membrane chromatography
09/25/1996EP0733103A1 Generation of high titers of recombinant aav vectors
09/25/1996EP0733067A1 N-terminally chemically modified protein compositions and methods
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0733046A1 Novel benzoyl guanidines, their production and their use in medicaments
09/25/1996EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
09/25/1996CN1131665A Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation
09/24/1996US5559232 Anticoagulants
09/24/1996US5559127 Fibrinogen receptor antagonists
09/19/1996WO1996028559A1 Method for the production of cationic peptides
09/19/1996WO1996028462A1 17-difluoromethylene-oestratrienes
09/19/1996WO1996028427A1 Benzamidine derivatives their preparation and their use as anti-coagulants
09/19/1996WO1996028168A1 Methods for the treatment of thrombosis
09/19/1996WO1996028153A1 Method of reducing prolonged coagulation time
09/19/1996WO1996028149A1 The pharmacological use of certain cystine derivatives
09/19/1996DE19509729A1 17-Difluormethylen-Estratriene 17-difluoromethylene estratrienes
09/19/1996CA2215362A1 Method for the production of cationic peptides
09/19/1996CA2215201A1 17-difluoromethylene-estratrienes
09/19/1996CA2214831A1 The pharmacological use of certain cystine derivatives
09/18/1996EP0732102A2 Composite for the treatment of acute myocardial infarction containing hirudin and acetylsalicyclic acid
09/18/1996EP0731812A1 POLY-beta-1-4-N-ACETYLGLUCOSAMINE
09/18/1996EP0731810A1 Double-chain hemoregulatory peptides
09/18/1996EP0643780B1 Multiple solvent cleaning system
09/18/1996CN1131438A Protein having TPO activity
09/18/1996CN1131416A Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
09/18/1996CN1131393A Biochemically balanced peritoneal dialysis solutions
09/18/1996CN1131153A 1-oxy-2-(phenylsulfonamido-) amyl piperidine derivant, its preparation method and medicinal use thereof
09/18/1996CN1131026A Shengbaisan powder medicine for umbilicus and preparation and use method
09/17/1996US5556977 Antiagglomerants for cells, anticoagulants, antiischemic agents using pyridinylpiperazine derivatives
09/17/1996US5556941 Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
09/17/1996US5556870 Use of leflunomide for inhibiting interleukin 1 beta
09/17/1996US5556864 Treatment of circulatory diseases and psychosis
09/17/1996US5556862 Pharmaceutical compositions containing isoquinoline derivatives
09/17/1996US5556854 Cardiovascular disorders and/or neurogenerative disorders
09/17/1996US5556766 Method of producing LYS-plasminogen
09/17/1996US5556621 Heat and acid resistant polypeptides or proteins as antiinflammatory agents
09/16/1996CA2171509A1 Method of treating acute myocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment
09/12/1996WO1996027380A1 Reduction of infarct volume using citicoline
09/12/1996WO1996021016A3 New staphylokinase derivatives
09/12/1996WO1996020718A3 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
09/12/1996CA2213000A1 Reduction of infarct volume using citicoline
09/11/1996EP0730660A1 Chimeric proteins including protease nexin-1 variants
09/11/1996EP0730657A1 Composition for the in vivo production of therapeutic products
09/11/1996EP0730606A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
09/11/1996EP0730590A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
09/11/1996EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
09/11/1996EP0730473A1 Hirudin conjugates from hirudin and lipophilic compounds
09/11/1996EP0730457A1 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injuri
09/11/1996EP0540574B1 Anticoagulant peptides
09/11/1996EP0450066B1 Carbostyril derivatives
09/11/1996CN1130866A Anti-angiogenic compositions and method of use
09/11/1996CN1130626A Adhesion receptor antagonists
09/10/1996US5554594 Imidazolidine derivatives
09/10/1996US5554512 Isolated dna sequence encoding flt3 ligand polypeptide; expression vector comprising the sequence; host cell transformed or transfected with the vector; culture process for producing flt3-l polypeptide; nucleic acid sequences
09/06/1996WO1996026961A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
09/06/1996WO1996021035A3 Retroviral delivery of full length factor VIII
09/06/1996WO1996020719A3 Body fluid replacement solution
09/06/1996WO1996019965A3 Engraftment of hematopoietic cells from a primate donor to a primate recipient
09/06/1996CA2247207A1 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
09/04/1996EP0729475A1 Purification of hemoglobin
09/04/1996EP0729472A1 Piperidinylcamphorsulfonyl oxytocin antagonists
09/04/1996EP0729460A1 Substituted 5-ring heterocycles, their preparation and their use
09/04/1996EP0729362A1 TRANSDERMAL COMPOSITION OF N- N- 5- 4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-$g(a)-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
09/04/1996EP0355131B1 Acyl deoxyribonucleoside derivatives and uses thereof
09/04/1996CN1130402A Pro-urokinase mutants
09/03/1996US5552520 Such as somatostatin analogs or bombesin analogs
08/1996
08/29/1996WO1996026269A1 Thrombin preparation
08/29/1996WO1996026187A1 Fibrinogen receptor antagonists
08/29/1996WO1996025915A1 Improved hemostatic composition for treating gingival area
08/29/1996CA2213408A1 Improved hemostatic composition for treating soft tissue
08/29/1996CA2211890A1 Fibrinogen receptor antagonists
08/28/1996EP0728759A1 Heterocyclic compounds
08/28/1996EP0728758A1 Dioxopyrrolo-pyrrole derivatives
08/28/1996EP0728482A2 Use of hcp specific compounds to enhance erythropoiesis
08/28/1996EP0728210A1 Thrombin mutants
08/28/1996EP0728147A1 Receptor specific atrial natriuretic peptides
08/28/1996EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
08/28/1996EP0728134A1 6-oxo-nucleosides useful as immunosuppressants
08/28/1996EP0727995A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
08/27/1996US5550259 Dicitrate cyclic diester can be used to prevent or reduce the effects of calcification-related disease
08/27/1996US5550142 Phenyl heterocycles as cox-2 inhibitors
08/27/1996US5550118 Polyhydronorharman synthase inhibitors
08/27/1996US5550116 Anticoagulants
08/27/1996US5550042 Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996CA2004366C Anti-infection and antithrombogenic medical articles and method for their preparation
08/27/1996CA1338551C Medicament for thrombotic disorder containing t-pa
08/22/1996WO1996025498A2 Mpl ligand analogs
08/22/1996WO1996025440A1 Polymeric compounds
08/22/1996WO1996025427A1 Serine protease inhibitors
08/22/1996WO1996025426A1 Novel dipeptide amidines as thrombin inhibitors
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025403A1 α-SUBSTITUTED HYDRAZIDES HAVING CALPAIN INHIBITORY ACTIVITY
08/22/1996WO1996025045A1 Thiols to promote hematopoietic progenitor cell growth
08/22/1996CA2212830A1 Serine protease inhibitors
08/22/1996CA2211109A1 Novel thrombin inhibitors
08/22/1996CA2210000A1 Polymeric compounds
08/22/1996CA2208073A1 Alpha-substituted hydrazides having calpain inhibitory activity
1 ... 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 ... 671